- £4.51m
- £6.19m
- €7.97m
- 16
- 59
- 11
- 17
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.18 | 1.69 | 2.23 | 9.17 | 7.97 |
Cost of Revenue | |||||
Gross Profit | -0.078 | 0.088 | 0.256 | 1.63 | 0.968 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.21 | 4.14 | 6.88 | 13 | 17.6 |
Operating Profit | -7.03 | -2.46 | -4.65 | -3.83 | -9.63 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.25 | -3.58 | -5.84 | -4.7 | -10.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.25 | -3.58 | -5.84 | -4.7 | -10.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -6.99 | -3.76 | -5.76 | -4.7 | -10.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.99 | -3.76 | -5.76 | -4.7 | -10.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.223 | -0.147 | -0.107 | -0.059 | -0.082 |